Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Dose–Response Meta-Analysis of Randomized Clinical Trials Investigating the Effects of Omega-3 Supplementation on Body Weight in Patients With Cancer Cachexia Publisher Pubmed



Hosseini F1 ; Hemmati A1 ; Takabi FS2 ; Naeini F1 ; Shab Bidar S3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Science, Tehran, Iran
  2. 2. Department of Medical Physics, School of Medicine, Tehran University of Medical Science, Tehran, Iran
  3. 3. Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Science, Tehran, Iran

Source: Clinical Nutrition ESPEN Published:2024


Abstract

Background: Cachexia is one of the side effects of cancer diseases that can be reduced weight, and lower overall survival. Weight loss has been associated with adverse outcomes in both cancer patients and patients with benign diseases. There is no definitive treatment for fully reverse cachexia. studies showed higher levels of inflammatory markers in patient with cachectic cancer. Therefore, this study aimed to investigate the dose–response effects of omega-3 as an anti-inflammatory supplement on body weight in patients with cancer cachexia. Methods: Online databases including PubMed, Scopus, and Web of Science were systematically searched by relevant keywords up to January 2022. Random effect analysis was applied to perform meta-analysis. Subgroup analyses were performed to find heterogeneity sources. Quality assessment was conducted using Revised Cochrane Collaboration's tool II. Trim and fill analysis were also carried out in case of the presence of publication bias. The certainty in the evaluations was assessed by the GRADE approach. Results: Omega-3 supplementation resulted in a significant increase of body weight in patients with cancer cachexia when the age of study participants was ≥67 years and the baseline weight of them was ≤60 kg (WMD = 0.99; 95 % CI: 0.06, 1.92 and WMD = 1.22; 95 % CI: 0.14, 2.30, respectively). Also, there was a non-significant linear relationship between the dosage of omega-3 supplementation and body weight in patients with cancer cachexia. Conclusion: Omega-3 supplementation may be a promising agent to increase body weight in patients with cancer cachexia. Also, a non-significant linear relationship between the dosage of omega-3 supplementation and body weight was found in these patients. © 2023 European Society for Clinical Nutrition and Metabolism
Experts (# of related papers)
Other Related Docs
33. Cancer Cachexia: Diagnosis, Assessment, and Treatment, Critical Reviews in Oncology/Hematology (2018)